Krystal Biotech, Inc.
- Stock
- Ticker KRYS
- ISIN US5011471027
- Nasdaq
Performance, volatility and drawdowns of Krystal Biotech, Inc. since 09/2017, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $61,667. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −53.4% in 11/2021, measured from the peak in 03/2021. It took 9 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 91 | 88 | 96 | 98 | 107 | 116 | 119 | 127 |
| Operating income | 41 | 36 | 39 | 41 | 44 | 54 | 58 | 71 |
| EBITDA | 43 | 38 | 41 | 43 | 46 | 55 | 60 | 73 |
| Net income | 45 | 36 | 38 | 79 | 51 | 56 | 55 | 63 |
| Earnings per share | 1.53 | 1.20 | 1.29 | 2.66 | 1.70 | 1.83 | 1.79 | 2.05 |
| Balance sheet | ||||||||
| Total assets | 1,056 | 1,074 | 1,138 | 1,240 | 1,334 | 1,397 | 1,501 | 1,586 |
| Liabilities | 109 | 90 | 98 | 102 | 114 | 120 | 142 | 150 |
| Equity | 946 | 985 | 1,041 | 1,138 | 1,220 | 1,277 | 1,359 | 1,436 |
| Cash | 345 | 309 | 354 | 393 | 496 | 501 | 428 | 463 |
| Cash flow | ||||||||
| Operating cash flow | 53 | 31 | 53 | 40 | 78 | 80 | 75 | 91 |
| Capital expenditure | -0.8 | -6.2 | -1.9 | -1.7 | -2.1 | -7.1 | -3.6 | -1.0 |
| Free cash flow | 52 | 25 | 51 | 38 | 75 | 73 | 71 | 90 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2019 at +166.5%, weakest 2020 at +8.3%. 8 of 8 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | $2.05 |
| 3 Aug 2026 | $1.79 |
| 4 May 2026 | $1.83 |
| 17 Feb 2026 | $1.70 |
| 3 Nov 2025 | $2.66 |
| 4 Aug 2025 | $1.29 |
| 6 May 2025 | $1.20 |
| 19 Feb 2025 | $1.53 |
| 4 Nov 2024 | $0.91 |
| 5 Aug 2024 | $0.53 |
| 6 May 2024 | $0.03 |
| 26 Feb 2024 | $0.31 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €8.3bn
- Market cap in trading currency
- $9.15bn
- Enterprise value
- $8.24bn
- P/E
- 41.9
- P/S
- 19.47
- P/B
- 6.38
- EV/Sales
- 17.53
- EV/EBITDA
- 35.3
- Earnings yield
- 2.4%
- FCF yield
- 3.4%
Results (last four quarters)
- Revenue
- $470m
- Gross profit
- –
- EBITDA
- $234m
- Net income
- $225m
- Earnings per share
- $7.37
- Revenue per share
- $15.86
- Revenue growth
- +30.2%
- Earnings growth
- −20.5%
Profitability
- Gross margin
- –
- Operating margin
- 48.4%
- Net margin
- 47.9%
- Return on equity
- 17.5%
- Return on assets
- 14.2%
Balance sheet and cash flow
- Cash
- $912m
- Cash per share
- $30.77
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 7.89
- Book value per share
- $48.44
- Operating cash flow
- $324m
- Free cash flow
- $310m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 29.6m
- Volume
- 286,633
- Avg. volume 3 months
- 282,411
- Relative volume
- 1.0
Price and technicals
- Price
- $308.89
- 1 day
- −2.2%
- 52-week high
- $378.15
- 52-week low
- $204.23
- Distance to 52-week high
- −18.3%
- Distance to 52-week low
- +51.2%
- Distance to 50-day line
- −4.2%
- Distance to 200-day line
- −0.5%
- RSI (14)
- 47
- Volatility 1M
- 52.9%
Performance
- 1 week
- +1.2%
- 1 month
- −3.5%
- 3 months
- −9.6%
- 6 months
- +3.2%
- YTD
- +25.3%
- 1 year
- +51.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has KRYS performed since 09/2017?
$10,000 grew to $290,310 by 20 Nov 2026, which is +44.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is KRYS?
Volatility was 51.5% per year, measured on monthly returns. The largest decline from a peak was −53.4%, with the low in 11/2021.
How does KRYS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.1% per year at 15.7% volatility, KRYS returned +44.4% at 51.5%. The correlation of monthly returns was 0.23; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.